ATE515498T1 - Verfahren zur aufreinigung von montelukast und dessen aminsalzen - Google Patents

Verfahren zur aufreinigung von montelukast und dessen aminsalzen

Info

Publication number
ATE515498T1
ATE515498T1 AT07788281T AT07788281T ATE515498T1 AT E515498 T1 ATE515498 T1 AT E515498T1 AT 07788281 T AT07788281 T AT 07788281T AT 07788281 T AT07788281 T AT 07788281T AT E515498 T1 ATE515498 T1 AT E515498T1
Authority
AT
Austria
Prior art keywords
montelukast
purification
salts
amine salts
treo
Prior art date
Application number
AT07788281T
Other languages
English (en)
Inventor
Guillen Yolanda Gasanz
Llagostera Montserrat Monsalvatje
Escasany Pedro Talavera
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Application granted granted Critical
Publication of ATE515498T1 publication Critical patent/ATE515498T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
AT07788281T 2006-08-09 2007-08-07 Verfahren zur aufreinigung von montelukast und dessen aminsalzen ATE515498T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83685606P 2006-08-09 2006-08-09
EP06118690A EP1886998A1 (de) 2006-08-09 2006-08-09 Verfahren zur Reinigung von Montelukast und dessen Aminesalzen
PCT/EP2007/058180 WO2008017669A1 (en) 2006-08-09 2007-08-07 Purification process of montelukast and its amine salts

Publications (1)

Publication Number Publication Date
ATE515498T1 true ATE515498T1 (de) 2011-07-15

Family

ID=37625598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07788281T ATE515498T1 (de) 2006-08-09 2007-08-07 Verfahren zur aufreinigung von montelukast und dessen aminsalzen

Country Status (19)

Country Link
US (1) US8188285B2 (de)
EP (2) EP1886998A1 (de)
JP (1) JP5188501B2 (de)
KR (1) KR20090035696A (de)
CN (1) CN101501000B (de)
AT (1) ATE515498T1 (de)
AU (1) AU2007283615A1 (de)
CA (1) CA2657775A1 (de)
ES (1) ES2372414T3 (de)
HR (1) HRP20110575T1 (de)
IL (1) IL196303A (de)
MX (1) MX2009000524A (de)
NO (1) NO20091051L (de)
PL (1) PL2077996T3 (de)
PT (1) PT2077996E (de)
RU (1) RU2009108272A (de)
SI (1) SI2077996T1 (de)
WO (1) WO2008017669A1 (de)
ZA (1) ZA200900890B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008510840A (ja) 2005-07-05 2008-04-10 テバ ファーマシューティカル インダストリーズ リミティド モンテルカストの精製
KR101469015B1 (ko) * 2008-02-25 2014-12-05 주식회사 종근당 몬테루카스트의 제조방법 및 이에 사용되는 중간체
EP2265586A4 (de) * 2008-03-17 2012-10-03 Reddys Lab Ltd Dr Herstellung von montelukast und seinen salzen
KR101123292B1 (ko) 2008-09-26 2012-03-19 주식회사 엘지생명과학 몬테루카스트 나트륨염의 제조방법
WO2011121091A1 (en) 2010-03-31 2011-10-06 Krka, D.D., Novo Mesto Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein
KR100990046B1 (ko) * 2010-07-30 2010-10-26 동국제약 주식회사 신규한 몬테루카스트 4-할로 벤질아민염 및 이를 이용한 몬테루카스트 나트륨염의 제조방법
HUP1000425A2 (en) 2010-08-11 2012-03-28 Richter Gedeon Nyrt Process for the production of montelukast sodium
WO2012077133A1 (en) * 2010-12-07 2012-06-14 Ind-Swift Laboratories Limited Processes for preparation of montelukast sodium and purification of diol intermediate
CN102060762B (zh) * 2011-01-28 2013-05-29 海南美大制药有限公司 孟鲁司特化合物及其新制法
CN103570618A (zh) * 2013-09-30 2014-02-12 浙江车头制药股份有限公司 一种孟鲁司特钠盐的制备方法
CN105924392B (zh) * 2016-02-29 2018-03-02 山东新时代药业有限公司 一种孟鲁司特钠制备方法
CN105646344B (zh) * 2016-02-29 2018-08-14 山东新时代药业有限公司 一种孟鲁司特的纯化方法
CN105585524B (zh) * 2016-02-29 2018-03-02 山东新时代药业有限公司 一种由孟鲁司特酸制备孟鲁司特钠的方法
US10723721B2 (en) * 2017-07-24 2020-07-28 Interquim, S.A. Process for preparing and purifying the LFA-1 antagonist lifitegrast
JP2021536467A (ja) 2018-09-06 2021-12-27 インノファーマスクリーン インコーポレイテッド 喘息またはパーキンソン病の処置のための方法および組成物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8403224A (nl) * 1984-10-24 1986-05-16 Oce Andeno Bv Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
DK0480717T3 (da) * 1990-10-12 1999-02-08 Merck Frosst Canada Inc Umættede hydroxyalkylquinolinsyrer som leukotrienantagonister
TW416948B (en) * 1993-12-28 2001-01-01 Merck & Co Inc Process for the preparation of leukotriene antagonists
CN1420113A (zh) 2001-11-16 2003-05-28 北京上地新世纪生物医药研究所 孟鲁司特钠的制备方法及其制备中间体
CN1171873C (zh) 2001-12-26 2004-10-20 北京上地新世纪生物医药研究所 一种孟鲁司特钠的制备方法及其制备中间体
US20050107612A1 (en) * 2002-12-30 2005-05-19 Dr. Reddy's Laboratories Limited Process for preparation of montelukast and its salts
CA2528228C (en) * 2003-06-06 2011-09-20 Morepen Laboratories Limited A method for the preparation of montelukast acid and sodium salt thereof in amorphous form
ATE522507T1 (de) * 2003-10-10 2011-09-15 Synhton B V Montelukast in fester phase
EP1708708A1 (de) * 2004-01-30 2006-10-11 Teva Pharmaceutical Industries Ltd. Montelukast-freie säure-polymorphen
US7189853B2 (en) * 2004-04-15 2007-03-13 Dr. Reddy's Laboratories Limited Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts
JP2007532686A (ja) 2004-04-21 2007-11-15 テバ ファーマシューティカル インダストリーズ リミティド モンテルカストナトリウムを調製する方法
US7501517B2 (en) 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
US7829716B2 (en) 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
EP1812394B1 (de) * 2004-07-19 2011-03-02 Matrix Laboratories Ltd Verfahren zur herstellung von montelukast und salzen davon
PL205637B1 (pl) * 2004-10-22 2010-05-31 Inst Farmaceutyczny Sposób wytwarzania kwasu (R,E)-(1-{1-{3-[2-(7-chlorochinolin-2-ylo)etenylo]fenylo}-3-[2-(1-hydroksy-1-metyloetylo)fenylo] propylosulfanylometylo}cyklopropylo)octowego i/lub jego farmaceutycznie dopuszczalnych soli
JP2008510840A (ja) 2005-07-05 2008-04-10 テバ ファーマシューティカル インダストリーズ リミティド モンテルカストの精製
EP1940793A4 (de) 2005-07-05 2011-03-23 Matrix Lab Ltd Verfahren zur herstellung von montelukast
WO2007012075A2 (en) 2005-07-20 2007-01-25 Dr. Reddy's Laboratories Ltd. Preparation of montelukast
ES2403067T3 (es) 2005-12-13 2013-05-13 Msn Laboratories Limited Un procedimiento mejorado para la preparación de montelukast y sus sales farmaceúticamente aceptables
CA2632954A1 (en) 2005-12-23 2007-06-28 Glade Organics Private Limited An improved process for the manufacture of montelukast sodium
KR20080105070A (ko) 2006-02-21 2008-12-03 케마지스 리미티드 몬테루카스트 암모늄염의 신규한 다형체 및 그 제조 방법
US7528254B2 (en) 2006-02-27 2009-05-05 Chemagis Ltd. Process for preparing montelukast and salts thereof
WO2007107297A1 (en) 2006-03-17 2007-09-27 Synthon B.V. Montelukast amantadine salt
US20090281323A1 (en) 2006-04-12 2009-11-12 Glade Organics Private Limited Process for the manufacture of montelukast sodium
WO2008001213A1 (en) 2006-06-26 2008-01-03 Aurobindo Pharma Limited An improved process for the preparation of leukotriene receptor antagonist (montelukast sodium)
GB0614485D0 (en) 2006-07-21 2006-09-27 Pliva Istrazivanje I Razvoj D Process
WO2008015703A2 (en) 2006-08-04 2008-02-07 Matrix Laboratories Ltd Process for the preparation of montelukast and its salts thereof

Also Published As

Publication number Publication date
JP2010500325A (ja) 2010-01-07
WO2008017669A1 (en) 2008-02-14
PT2077996E (pt) 2011-09-13
IL196303A0 (en) 2009-09-22
EP1886998A1 (de) 2008-02-13
US8188285B2 (en) 2012-05-29
ZA200900890B (en) 2010-04-28
MX2009000524A (es) 2009-01-27
CN101501000A (zh) 2009-08-05
HRP20110575T1 (hr) 2011-09-30
SI2077996T1 (sl) 2011-10-28
ES2372414T3 (es) 2012-01-19
AU2007283615A1 (en) 2008-02-14
JP5188501B2 (ja) 2013-04-24
IL196303A (en) 2014-03-31
EP2077996B1 (de) 2011-07-06
PL2077996T3 (pl) 2011-11-30
KR20090035696A (ko) 2009-04-10
NO20091051L (no) 2009-05-05
US20090247759A1 (en) 2009-10-01
CN101501000B (zh) 2012-04-04
CA2657775A1 (en) 2008-02-14
EP2077996A1 (de) 2009-07-15
RU2009108272A (ru) 2010-09-20

Similar Documents

Publication Publication Date Title
ATE515498T1 (de) Verfahren zur aufreinigung von montelukast und dessen aminsalzen
ATE524944T1 (de) Verfahren und vorrichtung zur übermittlung von rückstandsinformationen
DE602006016326D1 (de) Kompakte vorrichtung, zusammensetzungen und verfahren zur reinigung von nukleinsäuren
ATE443038T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid
DE602006012274D1 (de) Verfahren und Vorrichtung zur Herstellung von Gruppe III Nitridkristall.
ATE362530T1 (de) Verfahren und vorrichtung zur reinigung von nukleinsäuren
DE502004009768D1 (de) Verfahren zur herstellung von dreiwertigen organophosphor-verbindungen
DE602005004354D1 (de) Verfahren zur Lokalisierung von Fluoreszenzmarkers
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
ATE445587T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
DE602006017995D1 (de) Verfahren zur herstellung von pregabalin und salzen daraus
DE602004020895D1 (de) Verfahren zur herstellung von kohlenstoffnanospulen
ATE394369T1 (de) Verfahren zur aufreinigung von mesotrion
DE60319095D1 (de) Verfahren zur Verzerrungskorrektur von Multifokus-Bilderstapeln
DE50302740D1 (de) Verfahren zur herstellung von verküpbaren organischen pigmenten
ATE336464T1 (de) Verfahren zur aufreinigung von blausäure
DE602005014035D1 (de) Verfahren zur Herstellung von Aminen
ATE458709T1 (de) Verfahren zur reinigung von radiomarkierten produkten unter verwendung eines reinigungsmittels auf einem feststoffträger
ATE438613T1 (de) Verfahren zur herstellung von anilinen
ATA2732004A (de) Verfahren zur herstellung von anagrelid hydrochlorid
DE502005003382D1 (de) Verfahren zur destillativen aufarbeitung von tetrahydrofuran
ATE518003T1 (de) Verfahren zur identifizierung von cd4+-t-zellen- antigenen
DE602006011824D1 (de) Verfahren zur Herstellung von Schlämmen
ATE420168T1 (de) Verfahren zur herstellung von extrachromosomalen nukleinsäuremolekülen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties